Tumor lymphangiogenesis in head and neck squamous cell carcinoma - A morphometric study with clinical correlations

被引:144
作者
Franchi, A
Gallo, O
Massi, D
Baroni, G
Santucci, M
机构
[1] Univ Florence, Dept Human Pathol & Oncol, I-50134 Florence, Italy
[2] Univ Florence, Dept Otoneuroophtalmol Surg, Florence, Italy
关键词
head and neck squamous cell carcinoma (HNSCC); lymphangiogenesis; lymph node; metastasis; morphometric analysis; survival;
D O I
10.1002/cncr.20454
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
BACKGROUND. Tumor metastasis to regional lymph nodes via the lymphatic system represents the first step of dissemination in head and neck squamous cell carcinoma (HNSCC) and serves as a major prognostic indicator for disease progression and as a guide for therapeutic strategies. In the current study, the authors investigated whether tumor lymphangiogenesis may be related to the risk of lymph node metastasis and to clinical outcome in patients with HNSCC. METHODS. Immunostaining for the lymphatic marker D2-40 was used, and lymphangiogenesis was quantified within the tumor and in the peritumoral area in 52 HNSCC specimens using computer-assisted morphometric analysis. RESULTS. Lymphatic vessels were found to be significantly more numerous and larger in the peritumoral area compared with within the tumor, and the number and relative area of intratumoral and peritumoral lymphatics was significantly higher in HNSCC cases with lymph node metastasis. Multivariate analysis demonstrated that high peritumoral lymphangiogenesis (above the median value) was associated with an increased risk of developing lymph node metastasis. No correlation was found between tumor lymphangiogenesis and the disease-free or overall survival in the current series. CONCLUSIONS. The results indicate that peritumoral lymphangiogenesis may be an indicator of the risk of lymph node metastasis in patients with HNSCC. (C) 2004 American Cancer Society.
引用
收藏
页码:973 / 978
页数:6
相关论文
共 17 条
[1]
Beasley NJP, 2002, CANCER RES, V62, P1315
[2]
Birner P, 2001, INT J CANCER, V95, P29, DOI 10.1002/1097-0215(20010120)95:1<29::AID-IJC1005>3.0.CO
[3]
2-W
[4]
Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[5]
DADRAS SS, 1960, AM J PATHOL, V162, P1951
[6]
Fogt F, 2004, ONCOL REP, V11, P47
[7]
Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma [J].
Hall, FT ;
Freeman, JL ;
Asa, SL ;
Jackson, DG ;
Beasley, NJ .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2003, 129 (07) :716-719
[8]
A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors [J].
Kahn, HJ ;
Marks, A .
LABORATORY INVESTIGATION, 2002, 82 (09) :1255-1257
[9]
Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas [J].
Kahn, HJ ;
Bailey, D ;
Marks, A .
MODERN PATHOLOGY, 2002, 15 (04) :434-440
[10]
Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours [J].
Marks, A ;
Sutherland, DR ;
Bailey, D ;
Iglesias, J ;
Law, J ;
Lei, R ;
Yeger, H ;
Banerjee, D ;
Baumal, R .
BRITISH JOURNAL OF CANCER, 1999, 80 (3-4) :569-578